AR

Avnish Rao

Active Director Director DIN 10468787
DIN 10468787 First appointment Jan 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Avnish Rao

Data last updated:

Avnish Rao is a Director at Ginsburg Drugs And Formulations Private Limited (since 2024). The company operates in Healthcare. Ginsburg Drugs And Formulations Private Limited reported revenue of ₹1.56 Cr (FY 2024).

DIN 10468787
Primary Designation Director
Industry Healthcare
First Appointment 19 Jan 2024
Oldest Company Age 22 yrs
Largest company Ginsburg Drugs And Formulations Private Limited · ₹1.56 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20242004₹1.56 Cr (FY 2024)Active

Board colleagues of Avnish Rao

Directorship timeline

Open interactive timeline →
Ginsburg Drugs And Formulations Private Limited
Premium access

Shareholding and investment profile for Avnish Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avnish Rao

Avnish Rao currently holds 1 directorship: Ginsburg Drugs And Formulations Private Limited (Director, since 19 Jan 2024, revenue ₹1.56 Cr (FY 2024)).

Avnish Rao was first appointed on 19 Jan 2024 as Director at Ginsburg Drugs And Formulations Private Limited.

The current boards of Avnish Rao's companies include Shanti Bhushan Rao (Ginsburg Drugs And Formulations Private Limited), Vasu Vinayak Rao (Ginsburg Drugs And Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available